The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Newborn Genetic Screening Market Research Report 2024

Global Newborn Genetic Screening Market Research Report 2024

Publishing Date : Oct, 2023

License Type :
 

Report Code : 1803210

No of Pages : 89

Synopsis
Newborn Genetic Screening involves testing newborns shortly after birth to identify genetic and metabolic disorders that might not be apparent at birth but can be treated or managed if detected early.
Global Newborn Genetic Screening market is projected to reach US$ 223.4 million in 2029, increasing from US$ 104 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Newborn Genetic Screening market research.
Public health initiatives, parental awareness, and advancements in medical genetics contribute to the widespread adoption of newborn genetic screening programs, promoting early intervention and improved outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Newborn Genetic Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Trivitron Healthcare
MASIMO CORPORATION
Covidien Plc
Nemours KidsHealth
NJ.gov
Agilent Technologies
Ge Healthcare
PERKINELMER
Natus Medical Incorporated
Waters
Bio-Rad Laboratories
Ab Sciex LLC
Segment by Type
Dry blood spot tests
Hearing screening tests
CCHD screening tests
Segment by Application
Clinical Laboratories
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Newborn Genetic Screening report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Genetic Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Dry blood spot tests
1.2.3 Hearing screening tests
1.2.4 CCHD screening tests
1.3 Market by Application
1.3.1 Global Newborn Genetic Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Genetic Screening Market Perspective (2018-2029)
2.2 Newborn Genetic Screening Growth Trends by Region
2.2.1 Global Newborn Genetic Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Newborn Genetic Screening Historic Market Size by Region (2018-2023)
2.2.3 Newborn Genetic Screening Forecasted Market Size by Region (2024-2029)
2.3 Newborn Genetic Screening Market Dynamics
2.3.1 Newborn Genetic Screening Industry Trends
2.3.2 Newborn Genetic Screening Market Drivers
2.3.3 Newborn Genetic Screening Market Challenges
2.3.4 Newborn Genetic Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Genetic Screening Players by Revenue
3.1.1 Global Top Newborn Genetic Screening Players by Revenue (2018-2023)
3.1.2 Global Newborn Genetic Screening Revenue Market Share by Players (2018-2023)
3.2 Global Newborn Genetic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Genetic Screening Revenue
3.4 Global Newborn Genetic Screening Market Concentration Ratio
3.4.1 Global Newborn Genetic Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Genetic Screening Revenue in 2022
3.5 Newborn Genetic Screening Key Players Head office and Area Served
3.6 Key Players Newborn Genetic Screening Product Solution and Service
3.7 Date of Enter into Newborn Genetic Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Genetic Screening Breakdown Data by Type
4.1 Global Newborn Genetic Screening Historic Market Size by Type (2018-2023)
4.2 Global Newborn Genetic Screening Forecasted Market Size by Type (2024-2029)
5 Newborn Genetic Screening Breakdown Data by Application
5.1 Global Newborn Genetic Screening Historic Market Size by Application (2018-2023)
5.2 Global Newborn Genetic Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Newborn Genetic Screening Market Size (2018-2029)
6.2 North America Newborn Genetic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Newborn Genetic Screening Market Size by Country (2018-2023)
6.4 North America Newborn Genetic Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Genetic Screening Market Size (2018-2029)
7.2 Europe Newborn Genetic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Newborn Genetic Screening Market Size by Country (2018-2023)
7.4 Europe Newborn Genetic Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Genetic Screening Market Size (2018-2029)
8.2 Asia-Pacific Newborn Genetic Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Newborn Genetic Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Newborn Genetic Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Genetic Screening Market Size (2018-2029)
9.2 Latin America Newborn Genetic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Newborn Genetic Screening Market Size by Country (2018-2023)
9.4 Latin America Newborn Genetic Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Genetic Screening Market Size (2018-2029)
10.2 Middle East & Africa Newborn Genetic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Newborn Genetic Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Newborn Genetic Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Trivitron Healthcare
11.1.1 Trivitron Healthcare Company Detail
11.1.2 Trivitron Healthcare Business Overview
11.1.3 Trivitron Healthcare Newborn Genetic Screening Introduction
11.1.4 Trivitron Healthcare Revenue in Newborn Genetic Screening Business (2018-2023)
11.1.5 Trivitron Healthcare Recent Development
11.2 MASIMO CORPORATION
11.2.1 MASIMO CORPORATION Company Detail
11.2.2 MASIMO CORPORATION Business Overview
11.2.3 MASIMO CORPORATION Newborn Genetic Screening Introduction
11.2.4 MASIMO CORPORATION Revenue in Newborn Genetic Screening Business (2018-2023)
11.2.5 MASIMO CORPORATION Recent Development
11.3 Covidien Plc
11.3.1 Covidien Plc Company Detail
11.3.2 Covidien Plc Business Overview
11.3.3 Covidien Plc Newborn Genetic Screening Introduction
11.3.4 Covidien Plc Revenue in Newborn Genetic Screening Business (2018-2023)
11.3.5 Covidien Plc Recent Development
11.4 Nemours KidsHealth
11.4.1 Nemours KidsHealth Company Detail
11.4.2 Nemours KidsHealth Business Overview
11.4.3 Nemours KidsHealth Newborn Genetic Screening Introduction
11.4.4 Nemours KidsHealth Revenue in Newborn Genetic Screening Business (2018-2023)
11.4.5 Nemours KidsHealth Recent Development
11.5 NJ.gov
11.5.1 NJ.gov Company Detail
11.5.2 NJ.gov Business Overview
11.5.3 NJ.gov Newborn Genetic Screening Introduction
11.5.4 NJ.gov Revenue in Newborn Genetic Screening Business (2018-2023)
11.5.5 NJ.gov Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Newborn Genetic Screening Introduction
11.6.4 Agilent Technologies Revenue in Newborn Genetic Screening Business (2018-2023)
11.6.5 Agilent Technologies Recent Development
11.7 Ge Healthcare
11.7.1 Ge Healthcare Company Detail
11.7.2 Ge Healthcare Business Overview
11.7.3 Ge Healthcare Newborn Genetic Screening Introduction
11.7.4 Ge Healthcare Revenue in Newborn Genetic Screening Business (2018-2023)
11.7.5 Ge Healthcare Recent Development
11.8 PERKINELMER
11.8.1 PERKINELMER Company Detail
11.8.2 PERKINELMER Business Overview
11.8.3 PERKINELMER Newborn Genetic Screening Introduction
11.8.4 PERKINELMER Revenue in Newborn Genetic Screening Business (2018-2023)
11.8.5 PERKINELMER Recent Development
11.9 Natus Medical Incorporated
11.9.1 Natus Medical Incorporated Company Detail
11.9.2 Natus Medical Incorporated Business Overview
11.9.3 Natus Medical Incorporated Newborn Genetic Screening Introduction
11.9.4 Natus Medical Incorporated Revenue in Newborn Genetic Screening Business (2018-2023)
11.9.5 Natus Medical Incorporated Recent Development
11.10 Waters
11.10.1 Waters Company Detail
11.10.2 Waters Business Overview
11.10.3 Waters Newborn Genetic Screening Introduction
11.10.4 Waters Revenue in Newborn Genetic Screening Business (2018-2023)
11.10.5 Waters Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Newborn Genetic Screening Introduction
11.11.4 Bio-Rad Laboratories Revenue in Newborn Genetic Screening Business (2018-2023)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Ab Sciex LLC
11.12.1 Ab Sciex LLC Company Detail
11.12.2 Ab Sciex LLC Business Overview
11.12.3 Ab Sciex LLC Newborn Genetic Screening Introduction
11.12.4 Ab Sciex LLC Revenue in Newborn Genetic Screening Business (2018-2023)
11.12.5 Ab Sciex LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’